- Directly inhibits the growth and spread of cancer cells in conditions like advanced renal cell carcinoma.
- Helps to reduce the size and impact of tumors in conditions such as soft tissue sarcoma.
Sale!
Votrient 400mg
PAZOPANIB TABLETS 400MG
| MRP | : |
|
| Price | : | ₹15,500.00 |
| You Save | : | ₹784.38 (4.82%) |
30 Tablet(s) In A Bottle
Votrient 400mg tablet contains pazopanib as its active ingredient. This medication belongs to the class of antineoplastic drugs known as tyrosine kinase inhibitors. It is prescribed for adults diagnosed with advanced kidney cancer that has metastasized to other organs.
Do not use Votrient 400mg tablet if you have an allergy to pazopanib or any other components of this medication. Prior to starting treatment, it is essential to inform your healthcare provider if you have any issues related to your kidneys, heart, lungs, or liver, as well as any bleeding disorders, gastrointestinal problems, or thyroid conditions. This tablet may elevate your blood pressure, so regular monitoring is advised during the course of treatment. Patients with kidney disease do not require any dose modifications.
Your physician will instruct you to discontinue Votrient 400mg tablet at least 7 days prior to any surgical or dental procedures, as it may interfere with the healing process. This medication is not suitable for individuals under the age of 18. Additionally, it may lead to infertility; therefore, consult your doctor before starting this treatment. Common side effects include diarrhea, high blood pressure, changes in hair color, nausea, and vomiting.
